System C Healthcare plc Acquires Bluestar UK Group Limited

System C Healthcare plcSystem C Healthcare PLC ("System C"), the provider of specialist IT products and services to the healthcare sector, today announces the acquisition of the Bluestar UK Group Limited ("Bluestar") for a maximum consideration of up to £3.0 million.

Bluestar is a specialist developer and supplier of innovative healthcare IT solutions. These include the 'Pathfinder' Radio-Frequency ID (RFID) system for tracking patients and equipment, the Kings Infection Control System, and the 'IGFlow' Information Governance product which helps healthcare providers manage confidential patient data. Bluestar also provides healthcare advisory services through its team of 30 consultants.

During the last two years, Bluestar has supplied software and services to over 25 NHS Trusts, and is well respected for work in patient safety, clinical benchmarking, and the creation of cost-effective diagnostic services such as regional pathology networks.

System C intends to use its scale and market presence to bring Bluestar technologies to a wider audience, and work is already underway to provide its 'IGFlow' Information Governance product as a data centre hosted service to multiple NHS Trusts.

Bluestar's products complement System C's Medway Sigma range of healthcare computer systems, and their products will be integrated with, and sold alongside, Medway Sigma. For example, Pathfinder will be used to offer patient and instrument tracking to System C's Patient Administration System (PAS), accident and emergency, and theatre system users. The Board believes that these advanced technology features represent an excellent fit with System C's new generation Medway Sigma software.

In addition to Bluestar's range of complementary software products, Bluestar's healthcare IT services also strongly complements those of System C. Bluestar offers programme office support, business case production and change management as well as more traditional IT services such as network and infrastructure consulting. Combined with System C's design, build, test, deployment and healthcare improvement services, the expanded group is now in a position to offer a complete range of consulting services to the NHS, private and independent sectors.

The consideration for the acquisition is £0.4 million in cash on completion, with up to a further maximum of £2.6 million payable in cash over three years from completion. Payment of the maximum deferred consideration is subject to Bluestar achieving total aggregate profit before taxation of £2.12 million over the three year period, and is capped in each year based on annual targets. The consideration is to be funded from System C's existing resources.

In the year to 31 October 2008, Bluestar Group reported revenues of £2.7 million, profit before taxation of £0.2 million and had net assets at completion of £0.2 million.

System C's chief executive, Ian Denley, commented: "This is an excellent acquisition for System C which brings us a range of exciting healthcare technologies and products, and further strengthens our healthcare consulting capabilities."

Tony Corkett, founder and chief executive of Bluestar, highlighted the synergies between the companies. "System C's excellent track record in the development of healthcare IT solutions, combined with their proven deployment capability and experience, are a perfect match for us. Their reputation, their client base and their size will open up many new opportunities for us."

Related news articles:

About System C Healthcare plc
System C Healthcare plc (www.systemc.com), specialises in the design and development of clinical patient management and business intelligence software, and provides systems implementation and consulting services to the health sector.

System C Healthcare is quoted on the AIM market of the London Stock Exchange (SYS.L).

Most Popular Now

MEDICA 2024 + COMPAMED 2024: Adapted Hal…

11 - 14 November 2024, Düsseldorf, Germany. The final preparations for MEDICA 2024 and COMPAMED 2024 in Düsseldorf have begun. A total of more than 5,500 exhibitors from approximately 70 countries...

AI does Not Necessarily Lead to more Eff…

The use of artificial intelligence (AI) in hospitals and patient care is steadily increasing. Especially in specialist areas with a high proportion of imaging, such as radiology, AI has long...

Commission Joins Forces with Venture Cap…

The Commission has launched a Trusted Investors Network bringing together a group of investors ready to co-invest in innovative deep-tech companies in Europe together with the EU. The Union's investment...

Why the NHS is Seeking to Make Media Ser…

Opinion Article by Dean Moody, Healthcare Services Director, Airwave Healthcare. Tim Kelsey and Martha Lane Fox called for WiFi to be made available free of charge throughout the NHS back in...

An AI-Powered Pipeline for Personalized …

Ludwig Cancer Research scientists have developed a full, start-to-finish computational pipeline that integrates multiple molecular and genetic analyses of tumors and the specific molecular targets of T cells and harnesses...

Wearable Cameras Allow AI to Detect Medi…

A team of researchers says it has developed the first wearable camera system that, with the help of artificial intelligence (AI), detects potential errors in medication delivery. In a test whose...

Philips and Medtronic Advocacy Partnersh…

Royal Philips (NYSE: PHG, AEX: PHIA), a global leader in health technology, and Medtronic Neurovascular, a leading innovator in neurovascular therapies, today announced a strategic advocacy partnership. Delivering timely stroke...

AI could Transform How Hospitals Produce…

A pilot study led by researchers at University of California San Diego School of Medicine found that advanced artificial intelligence (AI) could potentially lead to easier, faster and more efficient...

New AI Tool Predicts Protein-Protein Int…

Scientists from Cleveland Clinic and Cornell University have designed a publicly-available software and web database to break down barriers to identifying key protein-protein interactions to treat with medication. The computational tool...

Great Start for Ideas and Innovations: D…

8 - 10 April 2025, Berlin, Germany. From 15 October to 15 November 2024, the DMEA invites experts from business, science, politics and practice to actively participate in shaping the congress...

Start-Ups will Once Again Have a Starrin…

11 - 14 November 2024, Düsseldorf, Germany. The finalists in the 16th Healthcare Innovation World Cup and the 13th MEDICA START-UP COMPETITION have advanced from around 550 candidates based in 62...

AI for Real-Rime, Patient-Focused Insigh…

A picture may be worth a thousand words, but still... they both have a lot of work to do to catch up to BiomedGPT. Covered recently in the prestigious journal Nature...